These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5546533)
1. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight]. Stormorken H Tidsskr Nor Laegeforen; 1971 Feb; 91(6):449-50. PubMed ID: 5546533 [No Abstract] [Full Text] [Related]
3. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)]. Loeliger EA Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223 [No Abstract] [Full Text] [Related]
4. [Acetylsalicylic acid and dipyridamole: aggregation inhibition in the rabbit experiment]. Polterauer P; Zekert F; Gottlob R Vasa; 1975; 4(4):397-402. PubMed ID: 1229648 [No Abstract] [Full Text] [Related]
5. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview. Weiss HJ Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351 [TBL] [Abstract][Full Text] [Related]
6. [Clinical use of anti-aggregative agents]. Bounameaux Y Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):223-34. PubMed ID: 4771351 [No Abstract] [Full Text] [Related]
7. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery]. Loeliger EA Ned Tijdschr Geneeskd; 1993 Dec; 137(51):2669. PubMed ID: 8278004 [No Abstract] [Full Text] [Related]
8. Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis. Moschos CB; Lahiri K; Lyons M; Weisse AB; Oldewurtel HA; Regan TJ Am Heart J; 1973 Jul; 86(1):61-8. PubMed ID: 4268306 [No Abstract] [Full Text] [Related]
13. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease. Rowe GG; Folts JD Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246 [TBL] [Abstract][Full Text] [Related]
15. [Persantin: coronary insufficiency, prevention of thrombosis, kidney failure, intrauterine asphyxia]. Heynen U Z Allgemeinmed; 1972 Feb; 48(5):246-50. PubMed ID: 5063268 [No Abstract] [Full Text] [Related]
16. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
17. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study]. Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723 [No Abstract] [Full Text] [Related]
18. [Thrombocytosis. Considerations on a case with intestinal thrombosis diagnosed at the age of 4 months and treated with platelet anti-aggregants]. Cottafava F; Brida Di PriĆ² S; Buono S; Nardelli E; Della Casa C; Boeri L; Dodero P Minerva Pediatr; 1981 Dec; 33(24):1199-202. PubMed ID: 7335028 [No Abstract] [Full Text] [Related]
19. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Turpie AG Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035 [TBL] [Abstract][Full Text] [Related]
20. [Use of calciparin, curantyl and polopirin S in the treatment of retinal vein thrombosis]. Karczewiczowa D; Krzystolikowa Z Klin Oczna; 1984 Mar; 86(3):129-30. PubMed ID: 6748552 [No Abstract] [Full Text] [Related] [Next] [New Search]